Optimization of beta-lactam dosing in critically ill patients with continuous veno-venous hemofiltration or augmented renal clearance.

Authors

Kristin Lytal PharmD, MSPGx, Parkview HealthFollow
Robert D. Beckett PharmD, BCPS, Parkview HealthFollow
Luke Keller PharmD, BCPS, BCCCP, Parkview HealthFollow
Michael Todt PharmD, BCCCP, Parkview HealthFollow

Abstract

Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA

This evaluation found that traditional dosing of beta-lactams found in practice is often (20 to 90%) suboptimal when compared to ideal evidence-based dosing, that optimizes efficacy while limiting adverse effects from drug toxicity.

Document Type

Poster

Publication Date

12-2024

Recommended Citation

Lytal, Kristin PharmD, MSPGx; Beckett, Robert D. PharmD, BCPS; Keller, Luke PharmD, BCPS, BCCCP; and Todt, Michael PharmD, BCCCP, "Optimization of beta-lactam dosing in critically ill patients with continuous veno-venous hemofiltration or augmented renal clearance." (2024). Pharmacy Residency. 35.
https://researchrepository.parkviewhealth.org/pharmresidency/35